MDS Podcast Getting involved in the MDS: a fruitful relationship
In this episode, Michele Matarazzo highlights the relevance of our society for the field and its members, with special guest Njideka Okubadejo.
Read MorePodcast: MDS PODCAST: Defining Parkinson's disease
MDS Podcast A cross-sectional study of PPMI participants using alpha-synuclein seed amplification as a biomarker
In this episode Dr. Tiago Outeiro talks with Dr. Andrew Siderowf about the exciting new results in his most recent publication on alpha-synuclein seed amplification assay. Read the article.
Read MoreMDS Podcast Inflammation is an early feature of Parkinson’s disease
Dr. Michele Matarazzo interviews Dr. Talene Yacoubian on an article recently published on the Movement disorders journal that reveals increased inflammatory markers in recently diagnosed patients with Parkinson’s disease without medication, suggesting the important role of inflammation from the early stages of the disease. Furthermore, inflammatory biomarkers are related to cognition. Journal CME is available…
Read MoreMDS Podcast Diagnosis of Late-Onset Wilson’s Disease
Dr. Christelle Nilles talks with Dr. Hugo Morales Briceno about the clinical presentations of Wilson’s disease patients with onset after 40 years and the challenges of diagnosing patients with atypical neurological manifestations. Read the article.
Read MoreMDS Podcast International Parkinson and Movement Disorder Society Mission and Structure
Sara Schaefer discusses the history, inner workings, and vision of the International Parkinson and Movement Disorder Society with current MDS President Francisco Cardoso.
Read MoreMDS Podcast Deep brain stimulation in Parkinson’s disease with cognitive impairment: real-world evidence
Deep brain stimulation (DBS) has long been considered a risky procedure for people with Parkinson’s disease and cognitive impairment. In this interview, Dr. Miocinovic presents real-world data, showing that DBS might be safe and useful in carefully selected patients with moderate cognitive impairment. Read the article.
Read MoreMDS Podcast History of Movement Disorders: The Finding of Alpha-Synuclein and Lewy Bodies
In this History of Movement Disorders Special Episode, Prof. Tiago Outeiro interviews Prof. Maria Grazia Spillantini about integral work involved in discovering the role alpha-synuclein plays in the development of Lewy bodies. She discusses where the field is now and what questions young researchers should start asking.
Read MoreMDS Podcast Hot topic: The gut microbiome in Parkinson’s
In this special Hot Topics episode, Dr. Filip Scheperjans discusses what we know and what we don’t yet know about the gut microbiome in Parkinson’s disease, theories of influencing pathways within the gut-brain axis, and future directions for exploring and altering the gut microbiome in this patient population to impact disease.
Read MoreMDS Podcast Pathological Validation of 2022 MSA Criteria
Sara Schaefer discusses with Dr. Eduardo de Pablo-Fernandez his recent paper in Movement Disorders providing retrospective pathological validation of the 2022 MDS MSA Criteria using specimens from the Queens Square Brain Bank. Read the article.
Read MoreMDS Podcast Walking through the falls: understanding gait with wearable sensors in Parkinson’s disease
In this paper, Dr. Vrustangkumar Shah and colleagues evaluated gait in patients with Parkinson’s disease in the lab and in real life, with and without levodopa through wearable sensors. Some measures are able to discriminate fallers from non-fallers in PD. Read the article.
Read More